Viridian Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

VRDN
Viridian Therapeutics

Last Price:

$17.07

Seasonality Move:

-12.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Viridian Therapeutics Stock Forecast

Over the next 52 weeks, Viridian Therapeutics has on average historically fallen by 15.2% based on the past 11 years of stock performance.
Viridian Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Is Viridian Therapeutics Stock Undervalued?

The current Viridian Therapeutics [VRDN] share price is $17.05. The Score for VRDN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
VRDN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Viridian Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Viridian Therapeutics has on average historically fallen by 15.2% based on the past 11 years of stock performance.

Viridian Therapeutics Stock Rating

Sell

Viridian Therapeutics (VRDN) is a Sell

Is Viridian Therapeutics overpriced?

Viridian Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

Viridian Therapeutics Stock Price History

Is VRDN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

viridiantherapeutics.com

52-Week Data

52-Week High:

27.20

52-Week Low:

9.90

Prediction Charts

Market Cap:

1.4B

Price in USD:

17.05

Volume:

419.2K

Beta:

1.23

Technical Analysis

SMA50:

14.58

SMA100:

14.37

SMA200:

17.53

52-Wk Change:

11.88%

Stock Predictions

Is Viridian Therapeutics stock public?

Yes, Viridian Therapeutics is a publicly traded company.
What is the Viridian Therapeutics stock quote today?

The Viridian Therapeutics stock price is 17.05 USD today.
How to buy Viridian Therapeutics stock online?

You can buy Viridian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-27	14.67	14.33	14.79	14.22
Jun-30	14.40	13.98	14.71	13.92
Jul-1	13.90	14.47	14.91	13.84
Jul-2	14.49	15.23	15.59	14.33
Jul-3	15.17	15.67	15.94	14.98
Jul-7	15.49	15.89	16.07	15.36
Jul-8	15.97	16.05	16.27	15.69
Jul-9	16.19	17.04	17.53	16.12
Jul-10	16.92	17.13	17.32	16.66
Jul-11	16.93	17.04	17.39	16.78
Jul-14	17.07	17.14	17.48	16.93
Jul-15	17.15	16.26	17.34	15.97
Jul-16	16.42	16.79	17.10	16.42
Jul-17	16.89	17.05	17.26	16.84

Viridian Therapeutics Earnings

Viridian Therapeutics Earnings Report: Per Share Viridian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viridian Therapeutics Forecast Revenue Growth

Viridian Therapeutics Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.02 per share, and an increase next year of $0.31 per share.

* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.